Phase II Study of Erlotinib in Japanese Patients with Pretreated EGFR Mutation Positive Non-Small Cell Lung Cancer: Lung Oncology Group in Kyushu, Japan (LOGIK0803)

Annals of Oncology - Tập 23 - Trang ix438 - 2012
K. Takayama1, Y. Nakanishi1, S. Kawakami2, K. Saruwatari3, K. Yamada4, R. Morinaga5, N. Aragane6, S. Nagata7, J. Kishimoto8, Y. Ichinose9
1Research Institute for Diseases of the Chest, Kyushu University, Fukuoka, Japan
2Respirology, Kyushu Kosei-Nenkin Hospital, Kitakyusyu, JAPAN
3Respiratory Medicine, Kumamoto University, Kumamoto, JAPAN
4Division of Respirology, Kurume University, Kurume, JAPAN
5Medical Oncology, Oita University Faculty of Medicine, Oita, JAPAN
6Blood and Lung and Tumor Instituite, Saga University, Saga, JAPAN
7Respiratory Medicine, University of Occupational and Environmental Health, Kitakyusyu, JAPAN
8Center for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan
9Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 23

ix438

Thông tin tác giả